Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.83M Buy
260,400
+180,900
+228% +$1.93M 0.01% 1129
2026
Q1
$882K Sell
79,500
-502,700
-86% -$6.4M ﹤0.01% 1764
2025
Q4
$9.54M Buy
582,200
+161,300
+38% +$2.51M 0.02% 666
2025
Q3
$5.63M Sell
420,900
-420,100
-50% -$4.97M 0.01% 971
2025
Q2
$10.8M Sell
841,000
-746,700
-47% -$8.96M 0.02% 598
2025
Q1
$16.4M Buy
1,587,700
+350,500
+28% +$4.51M 0.04% 401
2024
Q4
$15.7M Buy
+1,237,200
New +$16.4M 0.03% 405

Other funds holding PATH

PEAK6's PATH Position: Q2 2026 in Review

PEAK6 reduced its UiPath (PATH) stake by 58% in Q2 2026, selling an estimated $6.58M and leaving 437,828 shares worth $4.76M. The position accounts for 0.01% of the portfolio, ranked #877.

PEAK6 first reported a position in PATH in Q2 2025 and has held it in 4 quarters since. The position peaked at $11.7M in Q1 2026. 529 funds tracked by Wall St. Rank hold PATH as of Q2 2026.

  • PEAK6 held 437,828 shares of UiPath worth $4.76M as of Q2 2026.
  • PEAK6 sold 616,587 UiPath shares in Q2 2026, an estimated $6.58M.
  • UiPath made up 0.01% of PEAK6's portfolio in Q2 2026, its #877 holding.
  • PEAK6 first reported a position in UiPath in Q2 2025 and has held it in 4 quarters since.
  • PEAK6's UiPath position peaked at $11.7M in Q1 2026.
  • 529 funds tracked by Wall St. Rank held UiPath as of Q2 2026.

Based on PEAK6's 13F filing for Q2 2026, filed 13 Aug 2026.